Robert Sawyer
Gastroenterology · Mesa, AZNPI 1487616892
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,282 of the $4,990 with a category attached, or 85.8%. 25 manufacturers reported payments, led by AbbVie at 26.5% of the total. Reporting peaked in 2023 at $1,764 and has fallen 97.8% since, to $39 in 2025.
Across 231 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Braintree Laboratories, Inc.$536
- Pfizer$501
- Takeda Pharmaceuticals U.S.A., Inc.$455
- Johnson & Johnson$386
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$351
- plus $1K from 19 others
What the payments were for
- Food & beverage$4,28286%
- Education$1964%
- Gifts$51210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 64 | $1,324 |
| Braintree Laboratories, Inc. | 12 | $536 |
| Pfizer | 27 | $501 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $455 |
| Johnson & Johnson | 12 | $386 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $351 |
| Gilead | 12 | $211 |
| Bristol Myers Squibb | 12 | $193 |
| Merck | 9 | $167 |
| Organon | 6 | $133 |
| Regeneron Healthcare Solutions, Inc. | 5 | $133 |
| Redhill Biopharma Inc. | 5 | $91 |
| Ferring Pharmaceuticals Inc. | 5 | $89 |
| Amgen | 4 | $86 |
| Ardelyx, Inc. | 4 | $71 |
| Nestle Healthcare Nutrition Inc. | 2 | $57 |
| Lucid Diagnostics Inc. | 1 | $43 |
| QOL Medical, LLC | 2 | $36 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Boston Scientific | 1 | $26 |
| Celltrion USA Inc. | 1 | $21 |
| Oxford Immunotec USA Inc | 1 | $18 |
| Intercept Pharmaceuticals, Inc. | 1 | $14 |
| UCB, Inc. | 1 | $13 |
| Olympus America Inc. | 1 | $12 |
How this compares
$4,990 in reported general payments places this provider in the 55th percentile of 355 gastroenterology providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 65 | $1,200 |
| Esomeprazole Magnesium | 11 | $1,185 |
| Omeprazole | 15 | $260 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Mesa
- David LeffMesa$377K
- David TesslerMesa$191K
- Elisa FaybushMesa$30K
- Shahbaz QureshiMesa$25K
- Charles SapersteinMesa$25K
- Carlos Zapata AntigoniMesa$25K
- George WalkerMesa$15K
- Joel BrillParadise Valley$847K
- Daniel MelineScottsdale$795K
- David FleischerScottsdale$410K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.